Abstract
Calcium channel blockers, and specifically nifedipine, may be regarded as an additional tool in the management of hypertensive emergencies. Advantages of nifedipine, as compared to other drugs currently used in such emergencies include almost immediate onset and persistent duration of action, in frequent occurrence of side effects, increased cardiac output, ease of administration, efficacy in different types of hypertensive emergencies. In high blood pressure complicated by intracranial bleeding, the benefit of pressure reduction should be balanced against the risks specifically related to reduced smooth muscle vascular tone and contractility due to Ca blockade. If further clinical experience supports our observations, nifedipine or, more generally, calcium channel blocking agents, will find a place in the management of paroxysmal or persistent hypertension due to pheochromocytoma during preparation of the patient for surgical removal of the tumor in cases of malignant metastasizing tumor.
| Original language | French |
|---|---|
| Pages (from-to) | 59-65 |
| Number of pages | 7 |
| Journal | Archives des Maladies du Coeur et des Vaisseaux |
| Volume | 78 |
| Issue number | SPEC. NO. NOV. |
| Publication status | Published - 1985 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
LA NIFEDIPINE EN TANT QU'ANTIHYPERTENSEUR VASODILATATEUR D'EFFET RAPIDE. / Guazzi, M. D.; De Cesare, N.; Galli, C.
In: Archives des Maladies du Coeur et des Vaisseaux, Vol. 78, No. SPEC. NO. NOV., 1985, p. 59-65.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - LA NIFEDIPINE EN TANT QU'ANTIHYPERTENSEUR VASODILATATEUR D'EFFET RAPIDE
AU - Guazzi, M. D.
AU - De Cesare, N.
AU - Galli, C.
PY - 1985
Y1 - 1985
N2 - Calcium channel blockers, and specifically nifedipine, may be regarded as an additional tool in the management of hypertensive emergencies. Advantages of nifedipine, as compared to other drugs currently used in such emergencies include almost immediate onset and persistent duration of action, in frequent occurrence of side effects, increased cardiac output, ease of administration, efficacy in different types of hypertensive emergencies. In high blood pressure complicated by intracranial bleeding, the benefit of pressure reduction should be balanced against the risks specifically related to reduced smooth muscle vascular tone and contractility due to Ca blockade. If further clinical experience supports our observations, nifedipine or, more generally, calcium channel blocking agents, will find a place in the management of paroxysmal or persistent hypertension due to pheochromocytoma during preparation of the patient for surgical removal of the tumor in cases of malignant metastasizing tumor.
AB - Calcium channel blockers, and specifically nifedipine, may be regarded as an additional tool in the management of hypertensive emergencies. Advantages of nifedipine, as compared to other drugs currently used in such emergencies include almost immediate onset and persistent duration of action, in frequent occurrence of side effects, increased cardiac output, ease of administration, efficacy in different types of hypertensive emergencies. In high blood pressure complicated by intracranial bleeding, the benefit of pressure reduction should be balanced against the risks specifically related to reduced smooth muscle vascular tone and contractility due to Ca blockade. If further clinical experience supports our observations, nifedipine or, more generally, calcium channel blocking agents, will find a place in the management of paroxysmal or persistent hypertension due to pheochromocytoma during preparation of the patient for surgical removal of the tumor in cases of malignant metastasizing tumor.
UR - http://www.scopus.com/inward/record.url?scp=0022158028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022158028&partnerID=8YFLogxK
M3 - Articolo
C2 - 3937508
AN - SCOPUS:0022158028
VL - 78
SP - 59
EP - 65
JO - Archives des Maladies du Coeur et des Vaisseaux
JF - Archives des Maladies du Coeur et des Vaisseaux
SN - 0003-9683
IS - SPEC. NO. NOV.
ER -